Drug [Reference] Author, Year
rhDNase [45] Eisenberg JD et al., 1997
[50] Milla SE et al., 1998
hypertonic saline [11] Rodwell LT et al., 1996
[68] Elkins MR et al., 2006
[67] Rosenfeld M et al., 2011
tobramycin [84] Nikolaizik WH et al., 1996
[77] Ramsey BW et al., 1999
[32] Pai VB et al., 2001
[35]Alothman GA et al., 2002
colistin [92] Maddison J et al., 1994
[94] Cunningham S et al., 2001
[95] Hodson ME et al., 2002
[10] Alothman GA et al., 2005
AZLI [110] Retsch-Bogart GZ et al., 2008
[111] McCoy KS et al., 2008
[112] Retsch-Bogart GZ et al., 2009
[114] Oermann CM et al., 2010
Table 2: Key publications investigating BHR related to inhalation of rhDNase, hypertonic saline, tobramycin, colistin and AZLI